– USA, NV – Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, announced the election of Dan Henry as Chairman of the Board of Directors, succeeding Mark Newcomer who will continue in his role as President and CEO.
About Dan Henry
Dan Henry has served on Paysign’s Board of Directors since 2018 and currently chairs the Executive Compensation Committee. He is a veteran fintech executive with over 30 years of leadership experience, including roles as Co‑founder, President & COO of Euronet Worldwide (NASDAQ: EEFT) and CEO of NetSpend Corporation, where he led its IPO in 2010 and negotiated its $1.4 billion acquisition by TSYS in 2013. Most recently, he was CEO of Green Dot Corporation (NYSE: GDOT), a leading provider of banking and payment solutions. He has also served on the boards of The Brinks Company, Rx Savings Solutions and Dama Financial. Mr. Henry holds a B.S. in Business Administration with majors in Finance, Economics and Real Estate from the University of Missouri.
About Paysign
Paysign, Inc. operates at the intersection of fintech and healthcare, integrating advanced payment processing and program management with tailored technologies for the plasma, pharmaceutical and life sciences industries. Their breakthrough patient affordability solutions ensure patients receive the financial assistance they need to adhere to prescribed therapies by mitigating the effects of copay accumulators and maximizers. Paysign specializes in blood and plasma donor compensation programs, as well as comprehensive engagement and management platforms optimized for life sciences. Paysign’s proprietary processing architecture supports physical, virtual, mobile and bank-based payments with real-time transaction intelligence, enabling efficient, compliant and scalable program delivery. Through advanced reporting, analytics and in-house 24/7 bilingual customer support, Paysign delivers measurable value, exceptional service and a superior experience for donors, patients, healthcare providers, pharmaceutical manufacturers and program sponsors across their growing fintech healthcare ecosystem. The company is committed to improving efficiencies, reducing costs, streamlining communications, increasing program performance and providing actionable insights to those they serve.
For more information : https://paysign.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.